Overview
Gil Savir is an Of Counsel in the Securities & Capital Markets practice at Paul Hastings and is based in the firm’s New York office.
Gil provides sophisticated legal counsel to a diverse array of clients, including U.S., European and Israeli issuers and financial institutions, across a wide spectrum of capital-raising activities. His experience spans initial public offerings, equity offerings and public and private placements of investment-grade and convertible debt securities. Beyond transactional work, he serves as a trusted advisor to clients ranging from early-stage startups to well-established, globally recognized companies, offering strategic guidance on corporate governance, SEC reporting, complex transactions and other critical corporate matters. Gil's practice reflects a broad industry focus, encompassing cutting-edge sectors such as deep-tech, cybersecurity, biotechnology, fintech, consumer and retail, and mining.
Clients consistently commend his unparalleled ability to grasp the intricacies of their industries, align with their strategic objectives, and navigate complex legal landscapes. His innovative approach and commitment to delivering efficient, practical and impactful solutions make him a valued partner in advancing their business goals
Prior to joining Paul Hastings, Gil practiced capital markets at Davis Polk & Wardwell.
Education
- University of Michigan, J.S.D., 2016 (Scholarly Writing Award)
- University of Michigan, LL.M. 2013
- The Haim Striks School of Law, The College of Management, B.A., 2010
Representations
- LiveWire, the electric vehicle subsidiary of Harley Davidson, in its $1.77 IPO
- Wix.com Ltd.’s Rule 144A of $575 million aggregate principal amount of its 0% convertible senior notes due 2025, which includes $75 million
- Advising one of the largest fintech companies in the U.S. transportation segment in connection with its IPO
- Advising one of the largest expected Israeli IPOs for 2025 in the tech space
- Advised in the $7 billion taking public on Nasdaq and merger with DWAC of Trump Media & Technology Group
- Semperis in its $250 million credit agreements with JPMorgan and Hercules
- Paya Holdings Inc., a leading provider of integrated payment, in its $245 million SEC-registered offering of common stock
- Oak Street Health in its $377.3 million IPO; Oak Street Health owns primary care centers for Medicare patients
- Nayax Ltd. in its ILS 767 million (approx. $233 million) IPO and listing on the Tel Aviv Stock Exchange and NYSE direct listing; Nayax has developed a world leading unattended commerce operating system and payments platform—It was the first initial public offering of a tech unicorn on the Tel Aviv Stock Exchange
- Super Hi in its $10 billion initial public offering and listing on NASDAQ
- CureVac N.V., a Germany-based global biopharmaceutical company, on its initial public offering and multiple follow-on offerings, including at-the-market offering
- Advised the underwriters in the approx. $64 million IPO by Molecular Partners AG, a clinical stage biopharmaceutical company
- Amdocs Limited in its $650 million SEC-registered debt offering
- Perion Network Ltd. in its $66 million follow-on offering
- Gamida Cell Ltd in multiple SEC-registered follow-on offerings of ordinary shares of; Based in Israel, Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases
- BiondVax Pharmaceuticals Ltd. in multiple SEC-registered offerings
- Max Stock Ltd., as the issuer, and Moose Holdco Ltd., Uri Max Ltd. and Oria & Iris Ltd. LP, as the selling shareholders in Max Stock’s IPO and listing on the Tel Aviv Stock Exchange of 45,000,000 ordinary shares pursuant to Rule 144A/ Reg S; Max Stock Ltd. is the largest chain of discount stores in Israel
- Cyteir Therapeutics Inc. in its $133.2 million IPO of 7,400,000 shares of common stock
- Advised the sales agents in the SEC-registered $500 million at-the-market offering program by MicroStrategy, a global leader in enterprise analytics software and services
- Advised in the $808 million merger with Brivo, Inc., a global leader in mobile, cloud-based access control in the real estate industry
- Digicel Group’s $4.4 billion capital structure high-yield notes offering
- Advised on the IPO and $1.1 billion acquisition of CSA Copper Mine from Glencore
- MGP Ingredients, Inc. in its Rule 144A offering of an aggregate principal amount of $201.25 million of 1.875% convertible senior notes due 2041
- Ormat Technologies, Inc.’s Rule 144A offering of an aggregate principal amount of $375 million of its 2.50% convertible senior notes due 2027; Ormat is a geothermal energy generation power plant company
- Advised certain shareholders of Lazydays in private placement of common sock and exchange of outstanding convertible preferred stock and SEC registered rights offering
- Amdocs Limited in its $650 million SEC-registered debt offering of 2.583% notes due 2030 and all ongoing cross border transactions
- ICL Group Ltd on multiple cross border transactions; ICL Group is a global specialty minerals company
- Advised selective fast-growing tech companies, including NYMhealth, IVIX, Silverfort, Pontera, Bluevine, Slice Global, Hopper Security, Semperis, Gong.io, Verbit.ai and Intsight Cyber Intelligence (acquired by Rapid7) regarding ongoing matters related to their financial rounds and ongoing corporate matter
news
- Paul Hastings Advised Certain Shareholders of Lazydays in Private Placement of Common Stock and Exchange of Outstanding Convertible Preferred Stock - November 15th, 2024
- Paul Hastings Advised Semperis on Growth Financing - June 21st, 2024
- Paul Hastings Advised Underwriters on Super Hi International’s Public Offering and Listing on the Nasdaq Global Market - May 22nd, 2024
- Paul Hastings Advised Lenders on $4.4 Billion Restructuring of Digicel - January 30th, 2024
- Paul Hastings Advised Metals Acquisition Limited in Acquisition of CSA Copper Mine from Glencore for $1.1 Billion - June 23rd, 2023